Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?
Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?
复制标题
高危心肌梗死后的血压目标:是时候更新指南了吗?
DOI:
10.1161/hypertensionaha.107.099291
复制
发表时间:
2008
期刊:
影响因子:
8.3
通讯作者:
C. Pepine
中科院分区:
文献类型:
--
作者:
S. Denardo;R. Anderson;C. Pepine
In this issue of Hypertension , Thune et al1 analyze data from the Valsartan in Acute Myocardial Infarction Trial to assess the effect of antecedent hypertension and post-myocardial infarction (MI) blood pressure (BP) on adverse cardiovascular outcomes. Their results for acute MI patients with antecedent hypertension support previous reports of increased risk for adverse cardiovascular outcomes. In addition, their results for all of the post-MI patients, regardless of antecedent hypertension status, with excessively high or low systolic BP (extrapolating their 3 BP categories, essentially a “V”-shaped plot), are consistent with a majority of reports focusing on hypertension management for post-MI patients (essentially “J”- or “U”-shaped curves). Finally, their results for post-MI excessively high or low diastolic BP reportedly deviated in a similar manner but not significantly. The lack of a significant deviation was ascribed by the authors to an inadequate number of patients for analysis (602; representing 5.7% of the total cohort).
Those patients with excessively high or low diastolic BP represent a small but significant subpopulation of the patients that we see with acute MI (larger than that reported by Thune et al,1 because patients selected for the Valsartan in …